MLchartDataset catalogue

anti-HER3/topoisomerase I inhibitor antibody-drug conjugate

Term · Oncology and biomedicine · MLC-T-ONC-010779

Any antibody-drug conjugate (ADC) that is composed of a monoclonal antibody directed against human epidermal growth factor receptor 3 (HER3; ErbB3) and conjugated to a cytotoxic DNA topoisomerase I inhibitor.

Table 1. Record
IdentifierMLC-T-ONC-010779
FieldOncology and biomedicine
Synonymsanti-HER3/Top-I inhibitor ADC; anti-HER3/TopIi ADC; anti-HER3/topoisomerase I inhibitor ADC
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010779",
  "term": "anti-HER3/topoisomerase I inhibitor antibody-drug conjugate",
  "field": "Oncology and biomedicine",
  "definition": "Any antibody-drug conjugate (ADC) that is composed of a monoclonal antibody directed against human epidermal growth factor receptor 3 (HER3; ErbB3) and conjugated to a cytotoxic DNA topoisomerase I inhibitor.",
  "synonyms": [
    "anti-HER3/Top-I inhibitor ADC",
    "anti-HER3/TopIi ADC",
    "anti-HER3/topoisomerase I inhibitor ADC"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-her3-topoisomerase-i-inhibitor-antibody-drug-conjugate/"
}

Record 1,887 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.